Tandem Diabetes Care
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $283,690 | $254,560 | $247,221 | $290,383 |
Gross Profit | 160,422 | 144,780 | 136,788 | 167,460 |
EBITDA | -875 | -13,738 | -13,745 | 11,252 |
EBIT | -5,388 | -18,208 | -18,249 | 6,757 |
Net Income | -7,085 | -21,168 | -20,393 | -589 |
Net Change In Cash | 283,690 | 254,560 | 247,221 | 290,383 |
Free Cash Flow | -5,506 | -38,680 | 4,786 | 3,104 |
Cash | 72,840 | 62,818 | 179,325 | 90,634 |
Basic Shares | 69,650 | 68,397 | 68,397 | 68,014 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,014,736 | $940,203 | $747,718 | $801,217 |
Gross Profit | 530,847 | 489,574 | 367,690 | 412,986 |
EBITDA | -174,699 | -82,678 | -196,460 | -74,209 |
EBIT | -192,365 | -99,285 | -212,175 | -88,539 |
Net Income | -204,710 | -96,025 | -222,611 | -94,594 |
Net Change In Cash | 1,014,736 | 940,203 | 747,718 | 801,217 |
Cost of Revenue | 100,509 | |||
Free Cash Flow | -29,669 | 4,994 | -58,614 | 16,367 |
Cash | 90,634 | 69,234 | 58,868 | 172,517 |
Basic Shares | 67,285 | 65,451 | 64,968 | 64,146 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.10 |
2026-06-30 | -$0.31 |
2026-03-31 | -$0.30 |
2025-12-31 | -$0.01 |